Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Malignant Lymphoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

March 2013
1. LEONG HS , Chen K, Hu Y, Lee S, et al
   Epigenetic regulator Smchd1 functions as a tumor suppressor.
   Cancer Res. 2013;73:1591-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2013
2. HO WT , Pang WL, Chong SM, Castella A, et al
   Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
   Cancer Res. 2013;73:652-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2012
3. DONATE C , Ody C, McKee T, Ruault-Jungblut S, et al
   Homing of human B cells to lymphoid organs and B cell lymphoma engraftment are controlled by cell adhesion molecule JAM-C.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2012
4. ITO K , Smith BR, Parashurama N, Yoon JK, et al
   Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YIN Z , Menendez D, Resnick MA, French JE, et al
   RAP80 is critical in maintaining genomic stability and suppressing tumor development.
   Cancer Res. 2012;72:5080-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2012
6. KIM TS , Lee DH, Kim SK, Shin SY, et al
   Mammalian sterile 20-like kinase 1 (Mst1) suppresses lymphoma development by promoting faithful chromosome segregation.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. NAVARRO A , Clot G, Royo C, Jares P, et al
   Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biological and clinical features.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. DUTTA C , Day T, Kopp N, van Bodegom D, et al
   BCL2 suppresses PARP1 function and nonapoptotic cell death.
   Cancer Res. 2012;72:4193-203.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LI Z , Graf NA, Herrmann K, Junger A, et al
   FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2012
10. DE ROOS AJ , Mirick DK, Edlefsen KL, Lacroix AZ, et al
    Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2012
11. NEWMAN B , Liu Y, Lee HF, Sun D, et al
    HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CHENG F , Wang H, Horna P, Wang Z, et al
    STAT3 INHIBITION AUGMENTS THE IMMUNOGENICITY OF B-CELL LYMPHOMA CELLS LEADING TO EFFECTIVE ANTITUMOR IMMUNITY.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. RAMKUMAR C , Kong Y, Cui H, Hao S, et al
    Smurf2 regulates the senescence response and suppresses tumorigenesis in mice.
    Cancer Res. 2012;72:2714-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2012
14. REN H , Tan ZP, Zhu X, Crosby K, et al
    Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
15. AGUIRRE-PORTOLES C , Bird AW, Hyman A, Canamero M, et al
    Tpx2 controls spindle integrity, genome stability, and tumor development.
    Cancer Res. 2012;72:1518-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
16. HARROLD JM , Straubinger RM, Mager DE
    Combinatorial Chemotherapeutic Efficacy in non-Hodgkins Lymphoma can be Predicted by a Signaling Model of CD20 Pharmacodynamics.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. DAL COL J , Mastorci K, Fae DA, Muraro E, et al
    Alpha-interferon/retinoic acid combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ROBERT F , Mills JR, Agenor A, Wang D, et al
    Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival.
    Cancer Res. 2012;72:747-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
19. GOLDSTEIN MJ , Kohrt HE, Houot R, Varghese B, et al
    Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137 Expressing Regulatory T Cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
20. O'BRIEN P , Morin P Jr, Ouellette RJ, Robichaud GA, et al
    The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.
    Cancer Res. 2011;71:7345-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
21. SOMMERMANN T , O'Neill K, Plas DR, Cahir-McFarland E, et al
    IKK{beta} and NF{kappa}B transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. DONDOSSOLA E , Gasparri AM, Colombo B, Sacchi A, et al
    Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.
    Cancer Res. 2011;71:5881-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. KUMMAR S , Chen A, Ji J, Zhang Y, et al
    Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.
    Cancer Res. 2011;71:5626-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PRITCHARD JR , Gilbert LA, Meacham CE, Ricks JL, et al
    Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response.
    Cancer Res. 2011;71:5850-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
25. GILBERT LA , Hemann MT
    Chemotherapeutic resistance: surviving stressful situations.
    Cancer Res. 2011;71:5062-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. COLOFF JL , Macintyre AN, Nichols AG, Liu T, et al
    Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
    Cancer Res. 2011;71:5204-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
27. MEHTA H , Gao Q, Galet C, Paharkova V, et al
    IGFBP-3 is a Metastasis Suppression Gene in Prostate Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: